Abidalo 2,5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

abidalo 2,5 mg filmom obložene tablete

krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 2,5 mg apiksabana

Abidalo 5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

abidalo 5 mg filmom obložene tablete

krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 5 mg apiksabana

Aboxoma 2,5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

aboxoma 2,5 mg filmom obložene tablete

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 2,5 mg apiksabana

Aboxoma 5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

aboxoma 5 mg filmom obložene tablete

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 5 mg apiksabana

Apiksaban Krka 2,5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

apiksaban krka 2,5 mg filmom obložene tablete

krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 2,5 mg apiksabana

Apiksaban Krka 5 mg filmom obložene tablete Хорватия - хорватский - HALMED (Agencija za lijekove i medicinske proizvode)

apiksaban krka 5 mg filmom obložene tablete

krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - apiksaban - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 5 mg apiksabana

Sitagliptin SUN Европейский союз - хорватский - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Zenalpha Европейский союз - хорватский - EMA (European Medicines Agency)

zenalpha

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psiholekti, hipnotici i sedativi - psi - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

Sitagliptin / Metformin hydrochloride Mylan Европейский союз - хорватский - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.